Tuesday, February 16th 2021 - Thursday, February 18th 2021
€995.00 for non-members
€795.00 for members
Biotechnology Innovation Organisation
BIO would like to offer Flanders a unique opportunity to engage with global investors, CEOs, and executives from R&D companies ready to establish new cross-border collaborations and investment partnerships.
Join us at the BIO CEO & Investor Digital Conference, the biopharma industry’s premier investor and banking event, focused on established and emerging publicly traded and select private biotech companies. The virtual 2021 event, taking place February 16-18, will showcase the Biotechnology Innovation Organization’s (BIO) perspective on the new U.S. Congressional agenda, the record setting pacing of biotech IPOs and the hottest clinical developments and industry catalysts.
With no travel or cost restraints, we encourage you to build on the momentum from JPM Week and make the valuable connections in advance of BIO’s International Convention (BIO Digital) with three-days of productive BIO One-on-One Partnering meetings with institutional investors, industry analysts, and senior business development executives seeking potential cross-border investments and licensing partners. View the 2020 partnering companies and participating investors.
The education program will span two-days of interactive and on demand sessions covering a mix of therapeutic areas, business development, digital health, patient advocacy, public policy, and next generation biotherapeutics, along with added content relevant to industry responses to COVID-19.
FLANDERS.BIO MEMBER BENEFIT
flanders.bio members benefit from a 20% discount bringing the registration fee to $795. Additional attendees from the same organization can register for only $695! Contact us to obtain your discount code.